Sort
11,323 grants matching “glioblastoma”
Imaging
$205,487Akiva Mintz · Wake Forest University Health Sciences · P01 · FY2017 · CA
Type-1 Antigen Presenting Cells in CNS Tumors - Key to Efficient Anti-Tumor T-Cel
$205,460Hideho Okada · University Of Pittsburgh At Pittsburgh · P01 · FY2013 · CA
Core 1: Biospecimen and Pathology Core (BiPC)
$205,445Fausto Rodriguez · University Of California Los Angeles · P50 · FY2025 · CA
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
$205,401James Culvin Morris · Clemson University · R21 · FY2023 · AI
Biorepository core and bioststistics
$205,235Bob S Carter · Massachusetts General Hospital · P01 · FY2015 · CA
Dual imaging and therapeutic targeting agents for glioblastoma
$205,200Ruiwu Liu · University Of California At Davis · R21 · FY2009 · CA
Elimination of Carcinogen-Induced Tumor Stem Cells by ATF5 Loss of Function.
$205,200James M Angelastro · University Of California At Davis · R21 · FY2009 · CA
A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy
$205,187Frederick T Chin · Stanford University · R21 · FY2017 · CA
Training Program in Translational Brain Tumor Research
$205,179Russell O Pieper · University Of California, San Francisco · T32 · FY2013 · CA
Nanoparticles for In Vivo Labeling of T Cells During Cancer Immunotherapy
$205,144Carlos M Rinaldi-Ramos · University Of Florida · R21 · FY2022 · CA
PROTEIN INTERACTION CORE
$205,100William J Britt · University Of Alabama At Birmingham · P30 · FY2011 · NS
High-resolution DT-MRI for differentiation of malignant glioma from radiation nec
$205,000Jinyuan Zhou · Johns Hopkins University · R21 · FY2009 · EB
Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)
$205,000Charles George Eberhart · Johns Hopkins University · R21 · FY2009 · AT
(PQ5) Assessing the contribution of mitochondrial heterogeneity to gliomagenesis using single cell approaches
$204,885Vivian Gama · Vanderbilt University · R21 · FY2019 · CA
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
$204,706Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanisms of Akt-dependent sensitivity to rapamycin
$204,651Joseph F Gera · Sepulveda Research Corporation · R01 · FY2009 · CA
Mechanisms of Akt-dependent sensitivity to rapamycin
$204,651Joseph F Gera · Sepulveda Research Corporation · R01 · FY2010 · CA
Therapeutic vulnerabilities associated with PTEN missense mutations
$204,531Alain Charest · Beth Israel Deaconess Medical Center · R21 · FY2021 · CA
A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma
$204,520Ashish Harish Shah · University Of Miami School Of Medicine · R21 · FY2024 · CA
EGFR activity in T cell-influenced glioma invasiveness & chemosensitivity
$204,493Christopher Jay Wheeler · Cedars-Sinai Medical Center · R21 · FY2007 · NS
Biorepository core and bioststistics
$204,486Bob S Carter · Massachusetts General Hospital · P01 · FY2016 · CA
Prognostic and predictive clinical and proteomic biomarker discovery in GBM
$204,179Andra Krauze · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Using artificial intelligence and MRI to address limitations in glioblastoma
$204,179Andra Krauze · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Advancing clinically meaningful AI algorithms to improve oncologic outcomes
$204,179Andra Krauze · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Proteogenomic characterization and biomarker discovery in glioblastoma
$204,179Andra Krauze · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA